|
Market Closed -
Nasdaq
00:00:00 19/09/2026 +04
|
5-day change | 1st Jan Change | ||
| 44.44 USD | -4.94% |
|
-18.02% | -43.83% |
| 09-10 | Ionis Pharmaceuticals, Inc. Presents at Wells Fargo 21st Annual Healthcare Conference, Sep-10-2026 08:45 AM | |
| 09-09 | BofA Adjusts Price Target on Ionis Pharmaceuticals to $91 From $93 | MT |
| Market Cap | 7.39B 6.44B 6.08B 5.52B 10.35B 709B 10.39B 72.84B 28.11B 360B 27.74B 27.13B 1,159B | P/E 2026 * |
-12.4x | P/E 2027 * | -23.2x |
|---|---|---|---|---|---|
| Enterprise Value | 7.28B 6.35B 6B 5.44B 10.2B 699B 10.24B 71.82B 27.72B 355B 27.36B 26.75B 1,143B | EV / Sales 2026 * |
7.9x | EV / Sales 2027 * | 5.41x |
| Free-Float |
99.05% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IONS | Delayed | |
CBOE
| IONS | Real-time | |
|
Boerse Muenchen
| ISI | Real-time | |
|
London S.E.
| 0JDI | Delayed | |
|
Borsa Italiana
| 1IONS | End-of-day quote | |
|
Mexican S.E.
| IONS * | End-of-day quote | |
|
Tradegate
| ISI | Real-time | |
|
Börse Stuttgart
| ISI | Delayed | |
|
Deutsche Boerse AG
| ISI | Delayed | |
|
Xetra
| ISI | Delayed |
Last Transcript: Ionis Pharmaceuticals, Inc.
| 1 day | -4.94% | ||
| 1 week | -18.02% | ||
| Current month | -26.38% | ||
| 1 month | -25.46% | ||
| 3 months | -40.04% | ||
| 6 months | -37.99% | ||
| Current year | -43.83% |
| 1 week | 44.27 |  | 55.5 |
| 1 month | 44.27 | | 64.19 |
| Current year | 44.27 | | 86.74 |
| 1 year | 44.27 | | 86.74 |
| 3 years | 23.95 | | 86.74 |
| 5 years | 23.95 | | 86.74 |
| 10 years | 23.95 | | 86.74 |
| Manager | Title | Age | Since |
|---|---|---|---|
D. Walke
IRC | Investor Relations Contact | 60 | 01/07/2012 |
Brett Monia
CEO | Chief Executive Officer | 64 | 01/01/2020 |
Elizabeth Hougen
DFI | Director of Finance/CFO | 64 | 01/05/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Joseph Klein
BRD | Director/Board Member | 64 | 13/12/2005 |
| Director/Board Member | 73 | 01/05/2002 | |
Brett Monia
BRD | Director/Board Member | 64 | 25/03/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 31/08/26 | Others | Chief Technology Officer | 110 | 0.0001% | ||
| 31/08/26 | Others | Executive/Senior Manager | 58 | 0.0000% | ||
| 31/08/26 | Others | Founder | 98 | 0.0001% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.94% | -18.02% | -28.02% | +3.52% | 7.39B | |
| +0.11% | +2.71% | +0.33% | +28.59% | 46.28B | |
| -1.12% | +1.78% | +40.07% | +27.26% | 43.85B | |
| -3.04% | -6.29% | +322.27% | +517.36% | 40.93B | |
| -0.74% | +1.25% | +2.32% | +67.94% | 39.9B | |
| -0.50% | +0.67% | +11.79% | +40.51% | 29.5B | |
| -0.46% | +4.22% | +21.99% | +124.21% | 17.09B | |
| -0.97% | -10.17% | - | - | 15.55B | |
| -0.57% | +8.12% | +22.15% | +38.93% | 15.22B | |
| -3.14% | +31.91% | -10.60% | - | 14.05B | |
| Average | -1.39% | +1.58% | +42.48% | +106.04% | 26.97B | |
| Weighted average by Cap. | -1.13% | +1.33% | +62.00% | +126.33% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 921M 803M 759M 689M 1.29B 88.41B 1.3B 9.09B 3.51B 44.95B 3.46B 3.38B 145B | 1.38B 1.2B 1.13B 1.03B 1.93B 132B 1.94B 13.59B 5.24B 67.23B 5.18B 5.06B 216B |
| Net income | -572M -499M -471M -428M -801M -54.88B -805M -5.64B -2.18B -27.9B -2.15B -2.1B -89.78B | -320M -279M -263M -239M -448M -30.69B -450M -3.15B -1.22B -15.6B -1.2B -1.17B -50.21B |
| Net Debt | -103M -89.81M -84.8M -77M -144M -9.88B -145M -1.02B -392M -5.02B -387M -378M -16.17B | 68.31M 59.56M 56.24M 51.07M 95.69M 6.55B 96.09M 674M 260M 3.33B 257M 251M 10.72B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 18/09/26 | $44.44 | -4.94% | 7,369,358 |
| 17/09/26 | $46.75 | +4.26% | 4,079,573 |
| 16/09/26 | $44.84 | -5.10% | 7,958,214 |
| 15/09/26 | $47.25 | -8.15% | 6,812,465 |
| 14/09/26 | $51.44 | -5.11% | 5,974,753 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IONS Stock
Select your edition
All financial news and data tailored to specific country editions
